"Thimerosal has never undergone even one modern safety test. It was developed in 1927 and patented by Eli Lilly in 1928. It was first tested on small animals and killed a variety of mice, rabbits and chicks. After the animals died from exposure to Thimerosal, the decision was made to administer it to 22 patients suffering from bacterial meningitis during an epidemic in Indianapolis, Indiana in 1929.
Of the 22 persons given Thimerosal, all died, most within a day or two of administration. The doctor overseeing the trial, on stipend from Eli Lilly, declared that the patients had all died of meningitis and that Thimerosal was not observed to have caused any problem when administered to his patients. With that declaration, and a subsequent one by Eli Lilly staff that Thimerosal has a low order of toxicity for man, even though it killed small animals, Thimerosal was introduced into the drug supply. Yet, despite warnings in the published scientific literature that Thimerosal was toxic, and despite opposition to its use in every decade since, Thimerosal has remained in the drug supply.
The first protest on record against this highly toxic mercury compound was made in 1935 by the Pittman Moore Company which declared that, after testing, it found Thimerosal “was unsuitable as a preservative in serum intended for use in dogs…”
The FDA, passive with regard to safety testing, has never provided the results of appropriate toxicological tests on Thimerosal. Factually, the vaccine makers who use Thimerosal as a preservative are required by law to conduct and submit the results of such safety tests to the FDA before the FDA can legally approve a vaccine. Yet, the FDA has yet to produce even one of these vaccine maker’s toxicity studies, demonstrating Thimerosal safe for administration to humans, despite the fact that these documents have been sought in a court of law."